FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Beth Thurberg

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Procedures

Co-author Network

Publications

TOP 3
Baodong Sun; Beth L Thurberg; Adviye A Tolun; William E Kraus; Stephanie Austin; Deeksha Bali; Yuan-Tsong Chen; Keri Fredrickson; Priya S Kishnani
Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for glycogen storage disease type III.
Songtao Li; Mats I Nilsson; Baodong Sun; Mark A Tarnopolsky; Beth L Thurberg; Deeksha Bali; Andrew Bird; Dwight D Koeberl
Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease.
Haiqing Yi; Beth L Thurberg; Stephanie Austin; Sarah Curtis; John Fyfe; Priya S Kishnani; Dwight D Koeberl; Baodong Sun
Characterization of a canine model of glycogen storage disease type IIIa.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Beth Thurberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Baodong Sun; Beth L Thurberg; Adviye A Tolun; William E Kraus; Stephanie Austin; Deeksha Bali; Yuan-Tsong Chen; Keri Fredrickson; Priya S Kishnani
Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for glycogen storage disease type III.
Molecular genetics and metabolism 2013;108(2):145-7.
2013: Songtao Li; Mats I Nilsson; Baodong Sun; Mark A Tarnopolsky; Beth L Thurberg; Deeksha Bali; Andrew Bird; Dwight D Koeberl
Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2013;27(1):34-44.
2012: Haiqing Yi; Beth L Thurberg; Stephanie Austin; Sarah Curtis; John Fyfe; Priya S Kishnani; Dwight D Koeberl; Baodong Sun
Characterization of a canine model of glycogen storage disease type IIIa.
Disease models & mechanisms 2012;5(6):804-11.
2012: Lisa D Hobson-Webb; Sean N Prater; Alan D Proia; Beth L Thurberg; Suhrad Banugaria; Priya S Kishnani
Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature.
Molecular genetics and metabolism 2012;106(4):462-9.
2012: Tatyana V Taksir; Beth L Thurberg; Emily Yandl; Denise Griffiths; Jennifer Johnson; Colleen L Maloney; Susan Ryan
Optimization of a histopathological biomarker for sphingomyelin accumulation in acid sphingomyelinase deficiency.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2012;60(8):620-9.
2012: Beth L Thurberg; Melissa P Wasserstein; Gerald F Cox; Fanny O'Brien; Susan Richards; Thomas Schiano; Margaret M McGovern
Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B).
The American journal of surgical pathology 2012;36(8):1234-46.
2012: Beth L Thurberg; Juan M Politei
Histologic abnormalities of placental tissues in Fabry disease: a case report and review of the literature.
Human pathology 2012;43(4):610-4.
2012: Yin-Hsiu Chien; Pei-Hsin Huang; Ni-Chung Lee; Wang-Tso Lee; Beth L Thurberg; Wuh-Liang Hwu
Early pathologic changes and responses to treatment in patients with later-onset Pompe disease.
Pediatric neurology 2012;46(3):168-71.
2012: Dwight D Koeberl; Songtao Li; Beth L Thurberg; Deeksha Bali; Jian Dai; Priya S Kishnani
β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease.
Molecular genetics and metabolism 2012;105(2):221-7.
2011: Xin Sheen Zhang; Beth L Thurberg; William Brondyk; John T Lydon; Peter A Piepenhagen
Biotherapeutic target or sink: analysis of the macrophage mannose receptor tissue distribution in murine models of lysosomal storage diseases.
Journal of inherited metabolic disease 2011;34(3):795-809.
2011: Yin-Hsiu Chien; Ni-Chung Lee; Hsiang-Ju Huang; Beth L Thurberg; Fuu-Jen Tsai; Wuh-Liang Hwu
Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening.
The Journal of pediatrics 2011;158(6):1023-1027.e1.
2010: Baodong Sun; Songtao Li; Andrew Bird; Haiqing Yi; Alex Kemper; Beth L Thurberg; Dwight D Koeberl
Antibody formation and mannose-6-phosphate receptor expression impact the efficacy of muscle-specific transgene expression in murine Pompe disease.
The journal of gene medicine 2010;12(11):881-91.
2010: Peter A Piepenhagen; Scott Vanpatten; Heather Hughes; James Waire; James Murray; Laura Andrews; Tim Edmunds; Michael O'Callaghan; Beth L Thurberg
Use of direct fluorescence labeling and confocal microscopy to determine the biodistribution of two protein therapeutics, Cerezyme and Ceredase.
Microscopy research and technique 2010;73(7):694-703.
2010: Gaelle Douillard-Guilloux; Nina Raben; Shoichi Takikita; Arnaud Ferry; Alban Vignaud; Isabelle Guillet-Deniau; Maryline Favier; Beth L Thurberg; Peter J Roach; Catherine Caillaud; Emmanuel Richard
Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease.
Human molecular genetics 2010;19(4):684-96.
2009: Yin-Hsiu Chien; Ni-Chung Lee; Beth L Thurberg; Shu-Chuan Chiang; Xiaokui Kate Zhang; Joan Keutzer; Ai-Chu Huang; Mei-Hwan Wu; Pei-Hsin Huang; Fuu-Jen Tsai; Yuan-Tsong Chen; Wuh-Liang Hwu
Pompe disease in infants: improving the prognosis by newborn screening and early treatment.
Pediatrics 2009;124(6):e1116-25.
2009: Sarah P Young; Haoyue Zhang; Deyanira Corzo; Beth L Thurberg; Deeksha Bali; Priya S Kishnani; David S Millington
Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker.
Genetics in medicine : official journal of the American College of Medical Genetics 2009;11(7):536-41.
2009: Allison Vitsky; James Waire; Robert Pawliuk; Arden Bond; Douglas Matthews; Emily Lacasse; Michael L Hawes; Carol Nelson; Susan Richards; Peter A Piepenhagen; Richard D Garman; Laura Andrews; Beth L Thurberg; Scott Lonning; Steve Ledbetter; Melanie C Ruzek
Homeostatic role of transforming growth factor-beta in the oral cavity and esophagus of mice and its expression by mast cells in these tissues.
The American journal of pathology 2009;174(6):2137-49.
2009: Beth L Thurberg; John T Fallon; Richard Mitchell; Thomas Aretz; Ronald E Gordon; Michael W O'Callaghan
Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy.
Circulation 2009;119(19):2561-7.
2009: Robin J Ziegler; Claire Brown; Christine Barbon; Anne Marie D'Angona; Edward H Schuchman; Laura Andrews; Beth L Thurberg; John M McPherson; Kenneth P Karey; Seng Cheng
Pulmonary delivery of recombinant acid sphingomyelinase improves clearance of lysosomal sphingomyelin from the lungs of a murine model of Niemann-Pick disease.
Molecular genetics and metabolism 2009;97(1):35-42.
2009: Jean C Lubanda; Ene Anijalg; Vladimír Bzdúch; Beth L Thurberg; Bernard Bénichou; Anna Tylki-Szymanska
Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease.
Genetics in medicine : official journal of the American College of Medical Genetics 2009;11(4):256-64.
2008: Cecile Rouleau; Maritza Curiel; William Weber; Robert Smale; Leslie Kurtzberg; James Mascarello; Carol Berger; Gina Wallar; Rebecca Bagley; Nakayuki Honma; Kazumasa Hasegawa; Isao Ishida; Shiro Kataoka; Beth L Thurberg; Khodadad Mehraein; Bruce Horten; Glenn Miller; Beverly A Teicher
Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7223-36.
2008: Richard L Sidman; Tatyana Taksir; Jonathan Fidler; Michael Zhao; James C Dodge; Marco A Passini; Nina Raben; Beth L Thurberg; Seng Cheng; Lamya S Shihabuddin
Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice.
Journal of neuropathology and experimental neurology 2008;67(8):803-18.
2007: Raymond I Cruz; Francisco J Hernandez-Ilizaliturri; Scott Olejniczak; George Deeb; Joy Knight; Paul Wallace; Beth L Thurberg; William Kennedy; Myron S Czuczman
CD52 over-expression affects rituximab-associated complement-mediated cytotoxicity but not antibody-dependent cellular cytotoxicity: preclinical evidence that targeting CD52 with alemtuzumab may reverse acquired resistance to rituximab in non-Hodgkin lymphoma.
Leukemia & lymphoma 2007;48(12):2424-36.
2007: Tatyana V Taksir; Denise Griffiths; Jennifer Johnson; Susan Ryan; Lamya S Shihabuddin; Beth L Thurberg
Optimized preservation of CNS morphology for the identification of glycogen in the Pompe mouse model.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2007;55(10):991-8.
2007: Michael L Hawes; William Kennedy; Michael W O'Callaghan; Beth L Thurberg
Differential muscular glycogen clearance after enzyme replacement therapy in a mouse model of Pompe disease.
Molecular genetics and metabolism 2007;91(4):343-51.
2006: Beth L Thurberg; Colleen Lynch Maloney; Charles Vaccaro; Kendra Afonso; Anne Chun-Hui Tsai; Edward Bossen; Priya S Kishnani; Michael O'Callaghan
Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease.
Laboratory investigation; a journal of technical methods and pathology 2006;86(12):1208-20.
2006: Priya S Kishnani; Marc Nicolino; Thomas Voit; R. Curtis Rogers; Anne Chun-Hui Tsai; John Waterson; Gail E Herman; Andrea Amalfitano; Beth L Thurberg; Susan Richards; Mark Davison; Deyanira Corzo; Yuan-Tsong Chen
Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease.
The Journal of pediatrics 2006;149(1):89-97.
2005: Yunxiang Zhu; Xuemei Li; Alison McVie-Wylie; Canwen Jiang; Beth L Thurberg; Nina Raben; Robert J Mattaliano; Seng Cheng
Carbohydrate-remodelled acid alpha-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice.
The Biochemical journal 2005;389(Pt 3):619-28.
2005: Bartholomew A Pederson; Carlie R Cope; Jose M Irimia; Jill M Schroeder; Beth L Thurberg; Anna A DePaoli-Roach; Peter J Roach
Mice with elevated muscle glycogen stores do not have improved exercise performance.
Biochemical and biophysical research communications 2005;331(2):491-6.
2005: Bartholomew A Pederson; Carlie R Cope; Jill M Schroeder; Micah W Smith; José M Irimia; Beth L Thurberg; Anna A DePaoli-Roach; Peter J Roach
Exercise capacity of mice genetically lacking muscle glycogen synthase: in mice, muscle glycogen is not essential for exercise.
The Journal of biological chemistry 2005;280(17):17260-5.
2005: Colleen M Lynch; Jennifer Johnson; Charles Vaccaro; Beth L Thurberg
High-resolution light microscopy (HRLM) and digital analysis of Pompe disease pathology.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2005;53(1):63-73.
2005: Nina Raben; Tokiko Fukuda; Abigail L Gilbert; Deborah de Jong; Beth L Thurberg; Robert J Mattaliano; Peter J Meikle; John J Hopwood; Kunio Nagashima; Kanneboyina Nagaraju; Paul H Plotz
Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;11(1):48-56.
2004: Yunxiang Zhu; Xuemei Li; Josephine Kyazike; Qun Zhou; Beth L Thurberg; Nina Raben; Robert J Mattaliano; Seng Cheng
Conjugation of mannose 6-phosphate-containing oligosaccharides to acid alpha-glucosidase improves the clearance of glycogen in pompe mice.
The Journal of biological chemistry 2004;279(48):50336-41.
2004: Beth L Thurberg; H Randolph Byers; Scott R Granter; Robert G Phelps; Ronald E Gordon; Michael O'Callaghan
Monitoring the 3-year efficacy of enzyme replacement therapy in fabry disease by repeated skin biopsies.
The Journal of investigative dermatology 2004;122(4):900-8.
2003: Nina Raben; M Danon; A L Gilbert; Sunita Dwivedi; B Collins; Beth L Thurberg; Robert J Mattaliano; Kanneboyina Nagaraju; Paul H Plotz
Enzyme replacement therapy in the mouse model of Pompe disease.
Molecular genetics and metabolism 2003;80(1-2):159-69.
2002: Beth L Thurberg; Helmut Rennke; Robert Colvin; Steven Dikman; Ronald E Gordon; A Bernard Collins; Robert J Desnick; Michael O'Callaghan
Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy.
Kidney international 2002;62(6):1933-46.